Vanderbilt-Ingram Cancer Center has started offering scalp cooling, which mitigates hair loss for patients receiving certain chemotherapy regimens.
The DigniCap Scalp Cooling System was launched this month at Vanderbilt-Ingram Cancer Center Belle Meade. It is available for patients with solid tumors from breast cancer, prostate cancer, ovarian cancer, uterine cancer and lung cancer.
Vanderbilt researcher P. Brent Ferrell, MD, is leading one of five projects selected by the 2022 NIBR (Novartis Institutes for BioMedical Research) Global Scholars Program.
Travis Osterman, DO, MS, assistant professor of Biomedical Informatics (DBMI), Hematology and Oncology and director of Cancer Clinical Informatics at Vanderbilt-Ingram Cancer Center (VICC), has been appointed to a new role as Associate Vice President for Research Informatics at Vanderbilt University Medical Center.
Nicole Kidman and Keith Urban have made a generous financial gift to Vanderbilt-Ingram Cancer Center in support of clinical trials for new and better therapies for breast cancer.
The Oscar-winning and Grammy-winning international cinema and music superstars have been longtime cancer research supporters. They live in Nashville, home of Vanderbilt-Ingram, which has internationally recognized breast cancer researchers and clinicians.
Cathy Eng, MD, the David H. Johnson Professor of Surgical and Medical Oncology, stressed the need for more patient participation and better funding for clinical trials to improve colorectal cancer treatment and outcomes during the White House Cancer Moonshot Colorectal Cancer Forum on Friday, March 10.
Vanderbilt-Ingram Cancer Center is launching a clinical trial that pairs an experimental vaccine with an established immunotherapy for recurrent, human papilloma virus (HPV)-related oropharyngeal cancer of the head and neck.
Kimryn Rathmell, MD, PhD, MMHC, chair of the Department of Medicine at Vanderbilt University Medical Center, is one of four Vanderbilt University faculty members elected this year to the American Academy of Arts & Sciences.
A liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers, according to data from a retrospective study presented at the AACR Annual Meeting 2023, held recently in Orlando, Florida.
Four Vanderbilt University Medical Center faculty members have been elected this year to membership in the American Society for Clinical
